196 related articles for article (PubMed ID: 20382349)
21. [Immune tolerance and control of CNS autoimmunity: from animal models to MS patients].
Liblau R; Cassan C
Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S12-22. PubMed ID: 18087225
[TBL] [Abstract][Full Text] [Related]
22. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic use of T regulatory cells.
Verbsky JW
Curr Opin Rheumatol; 2007 May; 19(3):252-8. PubMed ID: 17414951
[TBL] [Abstract][Full Text] [Related]
24. [Sympathetic nervous factors, pressure variability and organ damage in arterial hypertension].
Mancia G; Seravalle G; Grassi G
Ann Ital Med Int; 1997; 12(4):217-22. PubMed ID: 9773576
[TBL] [Abstract][Full Text] [Related]
25. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
Tlaskalová-Hogenová H; Stepánková R; Hudcovic T; Tucková L; Cukrowska B; Lodinová-Zádníková R; Kozáková H; Rossmann P; Bártová J; Sokol D; Funda DP; Borovská D; Reháková Z; Sinkora J; Hofman J; Drastich P; Kokesová A
Immunol Lett; 2004 May; 93(2-3):97-108. PubMed ID: 15158604
[TBL] [Abstract][Full Text] [Related]
26. Unique atheroprotective property of azelnidipine, a dihydropyridine-based calcium antagonist.
Nakamura K; Yamagishi S; Inoue H
Med Hypotheses; 2005; 65(1):155-7. PubMed ID: 15893134
[TBL] [Abstract][Full Text] [Related]
27. Blood pressure variability: clinical implications and effects of antihypertensive treatment.
Parati G; Ravogli A; Frattola A; Groppelli A; Ulian L; Santucciu C; Mancia G
J Hypertens Suppl; 1994 Jul; 12(5):S35-40. PubMed ID: 7965285
[TBL] [Abstract][Full Text] [Related]
28. Regulatory T cells in renal transplantation and modulation by immunosuppression.
López-Hoyos M; Segundo DS; Fernández-Fresnedo G; Marín MJ; González-Martín V; Arias M
Transplantation; 2009 Aug; 88(3 Suppl):S31-9. PubMed ID: 19667959
[TBL] [Abstract][Full Text] [Related]
29. Baroreflex function in hypertension: consequences for antihypertensive therapy.
Grassi G; Trevano FQ; Seravalle G; Scopelliti F; Mancia G
Prog Cardiovasc Dis; 2006; 48(6):407-15. PubMed ID: 16714160
[TBL] [Abstract][Full Text] [Related]
30. World Immune Regulation Meeting (WIRM)--III: special focus on regulatory and effector mechanisms.
Godoy L
Drug News Perspect; 2009 Dec; 22(10):623-6. PubMed ID: 20140282
[TBL] [Abstract][Full Text] [Related]
31. Regulation of therapeutic apoptosis: a potential target in controlling hypertensive organ damage.
Deblois D; Tea BS; Beaudry D; Hamet P
Can J Physiol Pharmacol; 2005 Jan; 83(1):29-41. PubMed ID: 15759048
[TBL] [Abstract][Full Text] [Related]
32. Mediators of target organ damage in hypertension: focus on obesity associated factors and inflammation.
Dawood T; Schlaich MP
Minerva Cardioangiol; 2009 Dec; 57(6):687-704. PubMed ID: 19942842
[TBL] [Abstract][Full Text] [Related]
33. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation.
Izcue A; Coombes JL; Powrie F
Immunol Rev; 2006 Aug; 212():256-71. PubMed ID: 16903919
[TBL] [Abstract][Full Text] [Related]
34. Animal models of endocrine/organ-specific autoimmune diseases: do they really help us to understand human autoimmunity?
Lam-Tse WK; Lernmark A; Drexhage HA
Springer Semin Immunopathol; 2002 Dec; 24(3):297-321. PubMed ID: 12503056
[TBL] [Abstract][Full Text] [Related]
35. Control of type 1 diabetes by CD4+Foxp3+ regulatory T cells: lessons from mouse models and implications for human disease.
Sgouroudis E; Piccirillo CA
Diabetes Metab Res Rev; 2009 Mar; 25(3):208-18. PubMed ID: 19214972
[TBL] [Abstract][Full Text] [Related]
36. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
Oparil S; Bakir SE
Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
[TBL] [Abstract][Full Text] [Related]
37. Regulatory T cells in primary immunodeficiency diseases.
Torgerson TR; Ochs HD
Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):515-21. PubMed ID: 17989528
[TBL] [Abstract][Full Text] [Related]
38. Role of regulatory T cells in gastrointestinal inflammatory disease.
van Driel IR; Ang DK
J Gastroenterol Hepatol; 2008 Feb; 23(2):171-7. PubMed ID: 18289352
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the renin-angiotensin system and target organ protection.
Iwanami J; Mogi M; Iwai M; Horiuchi M
Hypertens Res; 2009 Apr; 32(4):229-37. PubMed ID: 19262496
[TBL] [Abstract][Full Text] [Related]
40. [Drug therapy of arterial hypertension. Reflections and suggestions].
Franchi F; Fabbri G
Clin Ter; 1989 May; 129(4):299-313. PubMed ID: 2527124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
